Paradromics announced today that it kicked off a new partnership program to open collaboration on brain-computer interface (BCI) technology.
The study will evaluate the long-term use of Connexus BCI for its ability to safely restore speech and enable computer control for people with severe motor impairment. AUSTIN, Texas--(BUSINESS ...
Paradromics Inc., a neurotechnology company developing the highest data-rate brain-computer interface (BCI) platform, today announced the US FDA has granted Investigational Device Exemption (IDE) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results